Epitranscriptomic regulation of lipid oxidation and liver fibrosis via ENPP1 mRNA m6A modification
Open Access
- 9 September 2024
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 81 (1) , 1-20
Abstract
Background Dysregulated lipid oxidation occurs in several pathological processes characterized by cell proliferation and migration. Nonetheless, the molecular mechanism of lipid oxidation is not well appreciated in liver fibrosis, which is accompanied by enhanced fibroblast proliferation and migration. Methods We investigated the causes and consequences of lipid oxidation in liver fibrosis using cultured cells, animal models, and clinical samples. Results Increased ecto-nucleotide pyrophosphatase/phosphodiesterase (ENPP1) expression caused increased lipid oxidation, resulting in the proliferation and migration of hepatic stellate cells (HSCs) that lead to liver fibrosis, whereas fibroblast-specific ENPP1 knockout reversing these results. Elevated ENPP1 and N6-methyladenosine (m6A) levels were associated with high expression of Wilms tumor 1 associated protein (WTAP). Mechanistically, WTAP-mediated m6A methylation of the 3'UTR of ENPP1 mRNA and induces its translation dependent of YTH domain family proteins 1 (YTHDF1). Additionally, ENPP1 could interact with hypoxia inducible lipid droplet associated (HILPDA) directly; overexpression of ENPP1 further recruits HILPDA-mediated lipid oxidation, thereby promotes HSCs proliferation and migration, while inhibition of ENPP1 expression produced the opposite effect. Clinically, increased expression of WTAP, YTHDF1, ENPP1, and HILPDA, and increased m6A mRNA content, enhanced lipid oxidation, and increased collagen deposition in human liver fibrosis tissues. Conclusions We describe a novel mechanism in which WTAP catalyzes m6A methylation of ENPP1 in a YTHDF1-dependent manner to enhance lipid oxidation, promoting HSCs proliferation and migration and liver fibrosis. Graphical abstractKeywords
Funding Information
- National Natural Science Foundation of China (81600477, 81874354)
This publication has 41 references indexed in Scilit:
- ENPP1 K121Q polymorphism and type 2 diabetes mellitus in the Chinese population: a meta-analysis including 11 855 subjectsMetabolism, 2012
- Lipid Oxidation and Cardiovascular Disease: Introduction to a Review SeriesCirculation Research, 2010
- Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient miceJournal of Clinical Investigation, 2010
- Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver diseaseGut, 2010
- Further Evidence For the Role of ENPP1 in Obesity: Association With Morbid Obesity in FinnsObesity, 2008
- Association of Genetic Variation in ENPP1 With Obesity‐related PhenotypesObesity, 2008
- Adipose Is a Conserved Dosage-Sensitive Antiobesity GeneCell Metabolism, 2007
- NPP-type ectophosphodiesterases: unity in diversityTrends in Biochemical Sciences, 2005
- Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetesNature Genetics, 2005
- Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralizationProceedings of the National Academy of Sciences, 2002